IMTX — Immatics NV
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of canc...
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
- Industry
- Biotechnology
- Sector
- Healthcare
- Exchange
- NASD
- First trade date
- 2020-07-02
The interactive platform loads with JavaScript. Research tools are for informational purposes.